Evidence map›Paper›PMID 25540805›Full record

ArticleAnnals of clinical and translational neurology2014

Heterozygous Polg mutation causes motor dysfunction due to mtDNA deletions.

Satoshi Fuke, Mizue Kametani, Kazuyuki Yamada, Takaoki Kasahara, Mie Kubota-Sakashita, Gregory C Kujoth, Tomas A Prolla, Seiji Hitoshi, Tadafumi Kato

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. TheGenes · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Novel biallelic mutations in POLG gene: large deletion and missense variant associated with PEO.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Mitochondrial dynamics and transport in Alzheimer's disease.Molecular and cellular neurosciences · 2019
    Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Satoshi FukeLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute Wako, Saitama, Japan, 351-0198 ; Department of Integrative Physiology, Shiga University of Medical Science Otsu, Shiga, Japan, 520-2192.
Mizue KametaniLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute Wako, Saitama, Japan, 351-0198.
Kazuyuki YamadaResearch Resources Center, RIKEN Brain Science Institute Wako, Saitama, Japan, 351-0198.
Takaoki KasaharaLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute Wako, Saitama, Japan, 351-0198.
Mie Kubota-SakashitaLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute Wako, Saitama, Japan, 351-0198.
Gregory C KujothDepartment of Neurological Surgery, University of Wisconsin Madison, Wisconsin, 53792.
Tomas A ProllaDepartments of Genetics and Medical Genetics, University of Wisconsin Madison, Wisconsin, 53706.
Seiji HitoshiDepartment of Integrative Physiology, Shiga University of Medical Science Otsu, Shiga, Japan, 520-2192.
Tadafumi KatoLaboratory for Molecular Dynamics of Mental Disorders, RIKEN Brain Science Institute Wako, Saitama, Japan, 351-0198.
RIKEN Center for Brain Science · JPUniversity of Wisconsin–Madison · USShiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveMutations in nuclear-encoded mitochondrial DNA (mtDNA) polymerase (POLG) are known to cause autosomal dominant chronic progressive external ophthalmoplegia (adCPEO) with accumulation of multiple mtDNA deletions in muscles. However, no animal model with a heterozygous Polg mutation representing mtDNA impairment and symptoms of CPEO has been established. To understand the pathogenic mechanism of CPEO, it is important to determine the age dependency and tissue specificity of mtDNA impairment resulting from a heterozygous mutation in the Polg gene in an animal model.

methodsWe assessed behavioral phenotypes, tissue-specific accumulation of mtDNA deletions, and its age dependency in heterozygous Polg (D257A) knock-in mice carrying a proofreading-deficient mutation in the Polg.

resultsHeterozygous Polg (D257A) knock-in mice exhibited motor dysfunction in a rotarod test. Polg (+/D257A) mice had significant accumulation of multiple mtDNA deletions, but did not show significant accumulation of point mutations or mtDNA depletion in the brain. While mtDNA deletions increased in an age-dependent manner regardless of the tissue even in Polg (+/+) mice, the age-dependent accumulation of mtDNA deletions was enhanced in muscles and in the brain of Polg (+/D257A) mice.

interpretationHeterozygous Polg (D257A) knock-in mice showed tissue-specific, age-dependent accumulation of multiple mtDNA deletions in muscles and the brain which was likely to result in neuromuscular symptoms. Polg (+/D257A) mice may be used as an animal model of adCPEO associated with impaired mtDNA maintenance.

Identifiers

PMID25540805
PMCPMC4265062
OpenAlexW2043335839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.